Pharma company Rottapharm admitted to Italy stock listing
MILAN, June 30
MILAN, June 30 (Reuters) - The Italian stock exchange has cleared the listing on the market of ordinary shares in pharmaceutical company Rottapharm.
In a statement, the bourse said the date from which the shares will start trading will be disclosed at a later stage.
The group, controlled by Italy's Rovati family, aims to float a 40 percent stake in an IPO that values the group at up to 2.2 billion euros ($3 billion), sources close to the matter have told Reuters. ($1 = 0.7331 Euros) (Reporting by Danilo Masoni; Editing by Oleg Vukmanovic)
- U.S. nurse defies Maine's Ebola quarantine, takes bike ride |
- Clashes erupt as Israeli police kill Palestinian suspected of shooting Jewish far-rightist
- Apple's Cook: 'I'm proud to be gay'
- SoftBank's humanoid robot lands job as Nescafe salesman
- Ukraine, Russia, EU likely to agree gas supply deal on Thursday: officials